79 related articles for article (PubMed ID: 6510946)
21. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
[TBL] [Abstract][Full Text] [Related]
22. Effects of biological response modifiers on lung natural killer activity.
Lauzon W; Lemaire I
Immunopharmacol Immunotoxicol; 1991; 13(3):237-50. PubMed ID: 1719060
[TBL] [Abstract][Full Text] [Related]
23. Antiviral activity of biological response modifiers in a murine model of AIDS. Requirement for augmentation of natural killer cell activity and synergy with oral AZT.
Black PL; McKinnon KM; Wooden SL; Ussery MA
Int J Immunopharmacol; 1996 Nov; 18(11):633-50. PubMed ID: 9089007
[TBL] [Abstract][Full Text] [Related]
24. Role of natural killer and T-cells in interferon induced inhibition of spontaneous metastases of the B16F10L murine melanoma.
Markovic SN; Murasko DM
Cancer Res; 1991 Feb; 51(4):1124-8. PubMed ID: 1705166
[TBL] [Abstract][Full Text] [Related]
25. Effect of glucan and other adjuvants on the clearance of radiolabeled tumor cells from mouse lungs.
Proctor JW; Stiteler RD; Yamamura Y; Mansell PW; Winters R
Cancer Treat Rep; 1978 Nov; 62(11):1873-80. PubMed ID: 728905
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
Hanna N; Schneider M
J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
[TBL] [Abstract][Full Text] [Related]
27. Systemic administration of recombinant interleukin-6 in mice induces proliferation of lymphoid cells in vivo.
Puri RK; Leland P
Lymphokine Cytokine Res; 1992 Jun; 11(3):133-9. PubMed ID: 1391232
[TBL] [Abstract][Full Text] [Related]
28. Changes in natural killer cells activity in mice bearing subcutaneously implanted Lewis lung carcinoma.
Budzyński W
Arch Immunol Ther Exp (Warsz); 1984; 32(2):185-9. PubMed ID: 6487051
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
Hafner M; Falk W; Echtenacher B; Männel DN
Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121
[TBL] [Abstract][Full Text] [Related]
30. Acute non-immunological inflammation inhibits natural killer (NK) activity in the lungs and enhances metastatic development.
Florentin I; Nolibe D; Giroud JP
Int J Exp Pathol; 1991 Feb; 72(1):83-95. PubMed ID: 1653591
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of pulmonary metastases induced by decreased lung natural killer cell activity.
Nolibé D; Poupon MF
J Natl Cancer Inst; 1986 Jul; 77(1):99-103. PubMed ID: 3014200
[TBL] [Abstract][Full Text] [Related]
32. Effect of glucan on natural killer (NK) cells: further comparison between NK cell and bone marrow effector cell activities.
Lotzová E; Gutterman JU
J Immunol; 1979 Aug; 123(2):607-11. PubMed ID: 458151
[No Abstract] [Full Text] [Related]
33. Effects of the immunomodulator LS 2616 on growth and metastasis of the murine B16-F10 melanoma.
Kalland T
Cancer Res; 1986 Jun; 46(6):3018-22. PubMed ID: 3486041
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of glucocorticoid action on murine natural killer cell activity.
Cox WI; Holbrook NJ; Friedman H
J Natl Cancer Inst; 1983 Nov; 71(5):973-81. PubMed ID: 6580499
[TBL] [Abstract][Full Text] [Related]
35. NK cells rapidly remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivo.
Grundy MA; Zhang T; Sentman CL
Cancer Immunol Immunother; 2007 Aug; 56(8):1153-61. PubMed ID: 17160409
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells.
Laybourn KA; Hiserodt JC; Abruzzo LV; Varani J
Cancer Res; 1986 Jul; 46(7):3407-12. PubMed ID: 2939945
[TBL] [Abstract][Full Text] [Related]
37. Alteration in natural defense activity against NK-susceptible B16 melanoma cells after treatment with Corynebacterium parvum.
Karashima A; Taniguchi K; Yoshikai Y; Nomoto K
Immunobiology; 1991 Aug; 182(5):414-24. PubMed ID: 1916884
[TBL] [Abstract][Full Text] [Related]
38. Transient activation of tumor-associated T-effector/memory cells promotes tumor eradication via NK-cell recruitment: minimal role for long-term T-cell immunity in cure of metastatic disease.
Gu T; Kilinc MO; Egilmez NK
Cancer Immunol Immunother; 2008 Jul; 57(7):997-1005. PubMed ID: 18049819
[TBL] [Abstract][Full Text] [Related]
39. Correlation of suppressed natural killer cell activity with altered host resistance models in B6C3F1 mice.
Wilson SD; McCay JA; Butterworth LF; Munson AE; White KL
Toxicol Appl Pharmacol; 2001 Dec; 177(3):208-18. PubMed ID: 11749120
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of lung metastasis in mice by intravascular injection of dendritic cells and natural killer cells.
Lv HF; Cui F; Yu CH; Deng LL; Ji JJ; Lu D; Yang Y; Wang WX; Xu YQ
Biotechnol Lett; 2009 Nov; 31(11):1709-15. PubMed ID: 19590829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
